Overview

A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects

Status:
Terminated
Trial end date:
2010-06-10
Target enrollment:
0
Participant gender:
Male
Summary
The purpose of this study is to investigate the effect of drug A on its own and when it is given in combination with drug B on markers of brain activity. The study will 1. Assess the effects of drug A and drug B on muscle movement after brain stimulation; 2. Examine how the body handles (absorbs, distributes, breaks down and gets rid of) drug A and drug B when given in combination; 3. Examine the safety of drug A and drug B when given together.
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Anticonvulsants
Lamotrigine
Vofopitant
Criteria
Inclusion Criteria:

- Healthy subject

- Male aged 18-65

- Greater than 50kg weight

- BMI 19-29.9 kg/m2

Exclusion Criteria:

- Positive drug/alcohol screen

- Positive HIV antibody

- History of drug dependence

- History of neurological disease

- Pacemaker

- Smoker